About us

Aepodia S.A. (spin-off of a top 10 US Pharma Company) was created in March 2007 by a group of experts in early-phase clinical development. Since then, our company has grown and built a strong and a worldwide reputation in the early clinical drug development sector. We have established solid and effective collaborations with world pharmaceutical leaders, as well as with small biotech companies. The management and staff members have a background in pharmaceutical development that allows us to understand sponsor requirements and challenges and to meet their needs in an optimal way.

Our headquarters are located in Louvain-La-Neuve, Belgium, with offices in Paris-La Défense, France. Thanks to our strategic location in the center of Europe, we can cover the European phase I units. We also support clinical trials in the United-States and Singapore and provide easy access to patients.

Our mission

Satisfying client needs and expectations, providing them with a range of high-quality services through various collaborations. This is the reason why our clients choose to continuously work with us, increasing our collaboration and on-going trust.

Our vision

Aepodia aims to contribute to medical advancements by preventing and curing diseases, and providing strong expertise, experience and a highly skilled team to innovative pharmaceutical and biotechnologies companies.